{"page_content": "33\nA Message from Standard BioTools CEO\nStandard BioTools\u2122 , previously known as Fluidigm\u00ae , is driven by a  \nbold purpose \u2013 Unleashing tools to accelerate breakthroughs in human \nhealth\u2122 . Standard BioTools provides an established portfolio of \nessential, standardized technologies that empower customers to scale \nand accelerate their life sciences research through the delivery of \nconsistent, reliable, and repeatable results. \nConsistent with this vision, we strive to conduct our business in a \nmanner that demonstrates our concern for the global environment \nand our desire for the well-being of all people. We believe that good \ncorporate governance practices are essential to achieving this goal.\nThe Standard BioTools Environmental, Social, and Governance (ESG) \nReport comprises a published overview of our environmental, social, \nand governance efforts and practices.\nAs we continue to work toward operational excellence, our annual ESG \nReport will evolve with innovative approaches to conduct our business \nin a sustainable and environmentally conscious manner and improve \nour processes to ensure that we are evaluating our impact across our \nentire spectrum of stakeholders.\nMichael Egholm , \nPresident and Chief Executive Officer\n", "metadata": {"source": "NASDAQ_LAB_2022.pdf", "page": 2, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}